The Takeda Patient Assistance Program (PAP) provides patients with access to medications
for a variety of conditions.
In 2011, the Takeda Patient Assistance Program provided more than 70,000 patients with 183,000 prescriptions valued at over $110 million.
Can I Apply?
- 1. You are a legal resident of the United States. You must live
in the United States and for some assistance programs must provide proof of residency
with either a Social Security Number, Green Card Number or Visa Number.
- 2. You do not have prescription coverage through private or government programs.
- 3. If you are eligible for, or enrolled in, Medicare Part D, you may still apply – see Sections 4 and 5 of the application form for guidelines.
- a. Attach a copy of the Social Security Low Income Subsidy (LIS) denial letter, if applicable.
-
b. Applicants will be referred when income is less than 135% of
Federal Poverty
Level
(FPL) guidelines.
- c. For further information, applicants can refer to
www.socialsecurity.gov
or may call 1-800-772-1213 (TTY 1-800-325-0778).
- 4. Your total
household incomeYour yearly household income includes
all money that comes into your household. If you are married and live with your
spouse, you must include both of your incomes. You must also include income earned
by dependents living with you. does not exceed:
| Persons in Household |
Annual Income |
| 1 |
$33,510 |
| 2 |
$45,390 |
| 3 |
$57,270 |
| 4 |
$69,150 |
| 5 |
$81,030 |
Takeda Medicines Available through the Patient Assistance Program
MEDICATION (generic)
| These are the products Takeda has available to patients in the PAP: |
|---|
| AMITIZA (lubiprostone) |
EDARBYCLOR (azilsartan medoxomil/chlorthalidone) |
| DEXILANT (dexlansoprazole) |
Rozerem (ramelteon) |
| EDARBI (azilsartan medoxomil) |
ULORIC (febuxostat) |
EDARBI, EDARBYCLOR and ROZEREM are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.
AMITIZA is a trademark of Sucampo Pharmaceuticals, Inc. registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.
DEXILANT is a trademark of Takeda Pharmaceuticals U.S.A., Inc., registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.
ULORIC is a trademark of Teijin Pharma Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.
This program, as well as all Takeda Pharmaceuticals America, Inc. programs, can be discontinued or changed at any time without notice at the discretion of Takeda Pharmaceuticals America, Inc.